These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 3127896)
1. Experience with subcutaneous infusion ports in three hundred patients. Brothers TE; Von Moll LK; Niederhuber JE; Roberts JA; Walker-Andrews S; Ensminger WD Surg Gynecol Obstet; 1988 Apr; 166(4):295-301. PubMed ID: 3127896 [TBL] [Abstract][Full Text] [Related]
2. Subcutaneous infusion ports for administration of parenteral nutrition at home. Pomp A; Caldwell MD; Albina JE Surg Gynecol Obstet; 1989 Oct; 169(4):329-33. PubMed ID: 2506656 [TBL] [Abstract][Full Text] [Related]
3. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques]. Capaccioli L; Nistri M; Distante V; Rontini M; Manetti A; Stecco A Radiol Med; 1998 Oct; 96(4):369-74. PubMed ID: 9972217 [TBL] [Abstract][Full Text] [Related]
4. Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally-inserted central catheters. Cowl CT; Weinstock JV; Al-Jurf A; Ephgrave K; Murray JA; Dillon K Clin Nutr; 2000 Aug; 19(4):237-43. PubMed ID: 10952794 [TBL] [Abstract][Full Text] [Related]
5. [Benefits of totally implanted central venous access in patients with cancer]. Saito H; Kamada T; Sakurai Y; Hanawa M; Takamura A Gan To Kagaku Ryoho; 1992 Apr; 19(4):519-24. PubMed ID: 1558403 [TBL] [Abstract][Full Text] [Related]
6. [Role of totally implantable systems for long-term vascular access in the treatment of the neoplastic patient]. Aldrighetti L; Caterini R; Ronzoni M; Jannello A; Ferla G Minerva Chir; 1995 May; 50(5):447-54. PubMed ID: 7478055 [TBL] [Abstract][Full Text] [Related]
7. Radiologic placement of a low profile implantable venous access port in a pediatric population. Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746 [TBL] [Abstract][Full Text] [Related]
8. Experience with the intravenous totally implanted port in patients with gynecologic malignancies. Nelson BE; Mayer AR; Tseng PC; Schwartz PE Gynecol Oncol; 1994 Apr; 53(1):98-102. PubMed ID: 8175028 [TBL] [Abstract][Full Text] [Related]
9. Advances in venous access devices and nursing management strategies. Wickham RS Nurs Clin North Am; 1990 Jun; 25(2):345-64. PubMed ID: 2110664 [TBL] [Abstract][Full Text] [Related]
10. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Schwarz RE; Groeger JS; Coit DG Cancer; 1997 Apr; 79(8):1635-40. PubMed ID: 9118051 [TBL] [Abstract][Full Text] [Related]
11. The natural history of tunneled hemodialysis catheters removed or exchanged: a single-institution experience. Alomari AI; Falk A J Vasc Interv Radiol; 2007 Feb; 18(2):227-35. PubMed ID: 17327555 [TBL] [Abstract][Full Text] [Related]
12. Peripheral infusion ports for central venous access in patients with gynecologic malignancies. Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645 [TBL] [Abstract][Full Text] [Related]
13. The complications of central venous access systems: a study of 218 patients. Torramadé JR; Cienfuegos JA; Hernández JL; Pardo F; Benito C; González J; Balén E; de Villa V Eur J Surg; 1993; 159(6-7):323-7. PubMed ID: 8104491 [TBL] [Abstract][Full Text] [Related]
14. Do central venous catheters have advantages over arteriovenous fistulas or grafts? Quarello F; Forneris G; Borca M; Pozzato M J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685 [TBL] [Abstract][Full Text] [Related]
15. When should the "infected" subcutaneous infusion reservoir be removed? Barnes JR; Lucas N; Broadwater JR; Hauer-Jensen M Am Surg; 1996 Mar; 62(3):203-6. PubMed ID: 8607579 [TBL] [Abstract][Full Text] [Related]
16. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Ciresi DL; Albrecht RM; Volkers PA; Scholten DJ Am Surg; 1996 Aug; 62(8):641-6. PubMed ID: 8712561 [TBL] [Abstract][Full Text] [Related]
17. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation]. Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304 [TBL] [Abstract][Full Text] [Related]
18. Avoiding complications of long-term venous access. Henriques HF; Karmy-Jones R; Knoll SM; Copes WS; Giordano JM Am Surg; 1993 Sep; 59(9):555-8. PubMed ID: 8368659 [TBL] [Abstract][Full Text] [Related]
19. Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2. Eastman ME; Khorsand M; Maki DG; Williams EC; Kim K; Sondel PM; Schiller JH; Albertini MR Cancer; 2001 Feb; 91(4):806-14. PubMed ID: 11241250 [TBL] [Abstract][Full Text] [Related]
20. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma]. Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]